跳至主要内容
临床试验/NCT03621202
NCT03621202已完成不适用

A Clinical Study to Evaluate the Safety and Accuracy of the Saranas Early Bird Bleed Monitoring System for the Detection of Endovascular Procedure Related Bleeding Events

Saranas, Inc.9 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2018年8月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Saranas, Inc.
入组人数
66
试验地点
9
主要终点
Cohen's Kappa Coefficient (κ)

研究概览

简要总结

To evaluate the safety and accuracy of the Saranas EBBMS for the detection of access site related internal bleeding events during large-bore endovascular procedures.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥18 years of age
  • Willing and capable to sign an Informed Consent form
  • Planned endovascular procedure such as trans-femoral transcatheter aortic valve replacement (TAVR), balloon aortic valvuloplasty, percutaneous coronary intervention, complex or high-risk percutaneous coronary intervention requiring hemodynamic support device (Impella 2.5, Impella CP, and ECMO), endovascular aortic repair (EVAR), any other endovascular procedures requiring arterial or venous access or surgical insertion of hemodynamic support

排除标准

  • Subject is participating, or planning to participate in a clinical trial or study of an investigational product that may influence the data collected for this investigation
  • Inability to access artery or vein for the endovascular procedure
  • Current active bleeding
  • Pre-procedural conditions precluding the realization of a post-procedural CT scan
  • Pregnancy
  • Mental disability or any other lack of fitness, in the Investigator's opinion, to preclude subject's participation in or ability to complete the study as planned

结局指标

主要结局

Cohen's Kappa Coefficient (κ)

时间窗: Up to 8 hours post procedure

Statistic measures concordance in detecting bleeds between the Saranas EBBMS and post-procedural CT. Cohen suggested the Kappa result be interpreted as follows: values ≤ 0 as indicating no agreement and 0.01-0.20 as none to slight, 0.21-0.40 as fair, 0.41- 0.60 as moderate, 0.61-0.80 as substantial, and 0.81-1.00 as almost perfect agreement.

次要结局

  • Device Specificity in Bleeding Detection of the Saranas EBBMS as Compared to Post-procedural Computerized Tomography(Up to 8 hours post procedure)
  • Device Sensitivity in Bleeding Detection of the Saranas EBBMS as Compared to Post-procedural Computerized Tomography(Up to 8 hours post procedure)

研究者

发起方
Saranas, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验